ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors
Research output: Contribution to journal › Journal article › Research › peer-review
To investigate the relation between ankylosing spondylitis disease activity score (ASDAS), Bath ankylosing spondylitis disease activity index (BASDAI) and treatment response and biomarkers of inflammation (C-reactive protein (CRP), interleukin-6 (IL-6), YKL-40), angiogenesis (vascular endothelial growth factor (VEGF)), cartilage (C-terminal crosslinking telopeptide of type II collagen (CTX-II), matrix metalloproteinase-3 (MMP-3), total aggrecan, cartilage oligomeric matrix protein) and bone (C-terminal crosslinking telopeptide of type I collagen, osteocalcin) turnover in 60 patients with axial spondyloarthritis initiating tumour necrosis factor alpha (TNFa) inhibitor therapy.
Original language | English |
---|---|
Journal | Annals of the Rheumatic Diseases |
Volume | 70 |
Issue number | 8 |
Pages (from-to) | 1375-81 |
Number of pages | 7 |
ISSN | 0003-4967 |
DOIs | |
Publication status | Published - 2011 |
ID: 40166616